SEC Form 4 · accession 0001365916-16-000108
AMYRIS, INC. · AMRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Feb 12, 2016
Accepted (ET)
May 19, 2016 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365916
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant (Right to Buy)F3,F2 | $0.01 | Feb 12, 2016 | P | 285,714 | A | May 17, 2016 | Feb 12, 2021 | Common Stock | 285,714 | 285,714 | I |
Explanation of responses
- F1Purchase was made pursuant to that certain Note and Warrant Purchase Agreement dated as of February 12, 2016 by and among the Issuer and the purchasers set forth therein, including Biolding Investment SA.
- F2The exercisability of the warrants was subject to stockholder approval, which was obtained on May 17, 2016.
- F3The Reporting Person is a director of Biolding Investment SA ("Biolding") and indirectly holds a majority of Biolding's outstanding shares, and, as such, may be deemed to share voting and investment power over the securities held by Biolding. The Reporting Person disclaims beneficial ownership of the securities held by Biolding, except to the extent of his pecuniary interest therein.